Alzheimer's Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database.

J Alzheimers Dis Rep · 2018 · PMC6110392 · PMID 30159547

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

almost significantp = 0.1so close (0.05 < p ≤ 0.1)

showed a reduction in risk of Alzheimer’s disease in rheumatoid arthritis patients on prednisone [ 7 ]; unadjusted the effect is almost significant ( p = 0.1).

also in 1,858 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.